Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke
Phase 3-ready program complements Biogen’s ongoing development efforts in stroke Biogen will pay a $120...
Search for Articles
May 15, 2017
Apr 28, 2017
Simple New Test Might Be a Better Way to Diagnose Gestational Diabetes
Link to publication below: Mellitus Study Mentioned in "What to Expect" Magazine
Apr 27, 2017
Mellitus Reports Publication of Investigator-Initiated Study Supporting Glycated CD59 as a Novel Alternative for Gestational Diabetes Screening
Mellitus Reports Publication of Investigator-Initiated Study Supporting Glycated CD59 as a Novel Alternative for Gestational...
Apr 4, 2017
InfoBionic Names Industry Veteran Stuart Long Chief Executive Officer
InfoBionic Names Industry Veteran Stuart Long Chief Executive Officer Signals next phase of expansion with...
Mar 6, 2017
Herantis Pharma’s clinical study with Lymfactin advances to high dose level
Herantis Pharma’s clinical study with Lymfactin advances to high dose level Herantis Pharma PlcCompany release...
Feb 13, 2017
miRagen Therapeutics Completes merger with Signal Genetics and Concurrent $40.7M Equity Financing
BOULDER, CO – February 13, 2017 – Miragen Therapeutics, Inc. (Nasdaq: MGEN), a clinical-stage biopharmaceutical company...